Phacilitate Leaders World 

Sponsors & Exhibitors

Northwest Biotherapeutics

Exhibitor

Northwest Biotherapeutics is developing personalized DCVax® dendritic cell-based immunotherapies for both operable and inoperable solid tumors.  The Company is conducting a Phase III trial of DCVax-L for newly diagnosed Glioblastoma multiforme brain cancer in the US and Europe.  The Company is also conducting a 60-patient Phase I/II trial with DCVax-Direct for all types of inoperable solid tumors. 

Visit Website
View all Sponsors & Exhibitors
Loading
Get the latest industry insights and exclusive deals straight to your inbox

Get the latest industry insights and exclusive deals straight to your inbox